Xijiao Dihuang decoction relieves the erlotinib-induced dermatitis
- 1 February 2023
- journal article
- research article
- Published by Elsevier BV in Experimental Cell Research
- Vol. 423 (2), 113437
- https://doi.org/10.1016/j.yexcr.2022.113437
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Erlotinib-related skin toxicities: Treatment strategies in patients with metastatic non-small cell lung cancerJournal of the American Academy of Dermatology, 2013
- Epidermal EGFR Controls Cutaneous Host Defense and Prevents InflammationScience Translational Medicine, 2013
- Genetic Ablation of Epidermal EGFR Reveals the Dynamic Origin of Adverse Effects of Anti-EGFR TherapyScience Translational Medicine, 2013
- Role of Macrophages in the Pathogenesis of Atopic DermatitisMediators of Inflammation, 2013
- Metronomic Chemotherapy Combined With Bevacizumab and Erlotinib in Patients With Metastatic HER2-Negative Breast Cancer: Clinical and Biological ActivityClinical Breast Cancer, 2012
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor ReceptorPLOS ONE, 2012
- Characterisation of the cutaneous pathology in non-small cell lung cancer (NSCLC) patients treated with the EGFR tyrosine kinase inhibitor erlotinibEuropean Journal of Cancer, 2010
- Phytochemical and Biological Studies of PaeoniaceaeChemistry & Biodiversity, 2010
- Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in MiceCancer Research, 2009
- Keratinocytes and cytokinesVeterinary Immunology and Immunopathology, 2002